Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes

NCT: NCT06024928 · COMPLETED

NCT IDNCT06024928
StatusCOMPLETED
Start Date2024-06-18
Completion2025-12-16

Brief Summary

The purpose of this clinical trial is to test the safety and feasibility of using an Automated Insulin Device (AID) in people with Type 2 Diabetes under basal insulin injections to achieve safe and fast basal insulin titration. Participants will be randomized to either the control group or the experimental group. If in the experimental group, the participant will use an insulin pump with Control-IQ Technology (Tandem Diabetes Care) for ten days. Researchers will compare the glycemic control of the experimental group to the control group.

Frequently Asked Questions

What is Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes?

Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes is a clinical trial registered under NCT06024928. Current status: COMPLETED.

What is the status of NCT06024928?

The current status of NCT06024928 (Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes) is: COMPLETED.

When did Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes start?

Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes started on 2024-06-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑